Triiodothyronine prevents tissue hypoxia in experimental sepsis: potential therapeutic implications
Main Authors: | Iordanis S. Mourouzis, Athanasios I. Lourbopoulos, Athanasios G. Trikas, Ioulia K. Tseti, Constantinos I. Pantos |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2021-04-01
|
Series: | Intensive Care Medicine Experimental |
Online Access: | https://doi.org/10.1186/s40635-021-00382-y |
Similar Items
-
Use of triiodothyronine to treat critically ill COVID-19 patients: a new clinical trial
by: Constantinos Pantos, et al.
Published: (2020-05-01) -
Triiodothyronine for the treatment of critically ill patients with COVID-19 infection: A structured summary of a study protocol for a randomised controlled trial
by: Constantinos Pantos, et al.
Published: (2020-06-01) -
The Emerging Role of TRα1 in Cardiac Repair: Potential Therapeutic Implications
by: Constantinos Pantos, et al.
Published: (2014-01-01) -
Translational Block in Stroke: A Constructive and “Out-of-the-Box” Reappraisal
by: Athanasios Lourbopoulos, et al.
Published: (2021-05-01) -
Thyroid Hormone and Tissue Repair: New Tricks for an Old Hormone?
by: Iordanis Mourouzis, et al.
Published: (2013-01-01)